Trainers In Maryland Warned About Use Of Amicar

The Maryland Thoroughbred Horsemen's Association has released a statement regarding the use of anti-bleeding medications for racehorses in training. Horsemen are encouraged to stop the use of these drugs immediately, particularly the use of aminocaproic acid, sold under the name Amicar.

Amicar and other anti-bleeding medications are used to prevent bleeding from horses that suffer from Exercise Induced Pulmonary Hemorrhage (EIPH).

Amicar and multiple other anti-bleeding medications were placed on the Prohibited List in 2013 under Association of Racing Commissioners International Uniform Classification Guidelines for Foreign Substances.

These medications were placed on this list because they cannot be regulated by withdrawal time guidelines, and the medications have no timeline in which they can be used in which they might not trigger a positive test post-race.

Any trainer who uses these medications runs the risk of his or her horse coming back with a positive drug test post-race.

Read more here.

The post Trainers In Maryland Warned About Use Of Amicar appeared first on Horse Racing News | Paulick Report.

Source of original post

Maryland THA Issues Warning on Adjunct Bleeder Medication

The Maryland Thoroughbred Horsemen's Association issued the following statement to its members Tuesday:

“Effective immediately, horsemen are urged to discontinue the use of any and all adjunct bleeder medications for horses in training, including in particular, aminocaproic acid–commonly called Amicar.

Amicar and several other adjunct bleeder medications were placed on the Prohibited List in 2013 under the Association of Racing Commissioners International Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Code and the National Uniform Medication Program. Aminocaproic acid, for example is a Class 4 substance and penalty Class C.

“It is important to understand that these medications cannot be regulated by withdrawal time guidance and/or a testing threshold and their use, no matter how far in advance of a race, may trigger a positive post-race test.

“Any trainer who chooses to continue the use of these medications for training in the future will run the risk of a post-race positive test.”

The post Maryland THA Issues Warning on Adjunct Bleeder Medication appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights